Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Goran Bencina, André Bento-Abreu, Ugne Sabale, Eleana Tsoumani, Valerie Laigle, Nicolas Dauby, Olivier Ethgen & Stina Salomonsson. (2023) Estimating the lifetime cost of vaccination in 23 European Countries: a modeling study. Expert Review of Vaccines 22:1, pages 148-160.
Read now
Read now
Yiwei Guo, Yong Yang, Qian Bai, Zhengwei Huang, Zongwu Wang, Dongxia Cai, Shuo Li, Xiaowei Man & Xuefeng Shi. (2021) Cost-utility analysis of newborn hepatitis B immunization in Beijing. Human Vaccines & Immunotherapeutics 17:4, pages 1196-1204.
Read now
Read now
Angela Bechini, Paolo Bonanni, Maddalena Grazzini, Diana Paolini, Giulio Arcangeli, Nicola Mucci, Costanza Bini, Emilia Tiscione, Beatrice Zanella & Sara Boccalini. (2021) Need to take special care of non-responders to hepatitis B vaccination among health-care workers, students and chronic patients. Human Vaccines & Immunotherapeutics 17:2, pages 580-582.
Read now
Read now
Lijie Yu, Jian Wang, Knut R. Wangen, Ruohan Chen, Elizabeth Maitland & Stephen Nicholas. (2016) Factors associated with adults' perceived need to vaccinate against hepatitis B in rural China . Human Vaccines & Immunotherapeutics 12:5, pages 1149-1154.
Read now
Read now
Edward Gibson, Najida Begum, Birgir Sigmundsson, Alfred Sackeyfio, Judith Hackett & Sankarasubramanian Rajaram. (2016) Economic evaluation of pediatric influenza immunization program compared with other pediatric immunization programs: A systematic review. Human Vaccines & Immunotherapeutics 12:5, pages 1202-1216.
Read now
Read now
Articles from other publishers (19)
Sara Boccalini, Benedetta Bonito, Beatrice Zanella, Davide Liedl, Paolo Bonanni & Angela Bechini. (2022) The First 30 Years of the Universal Hepatitis-B Vaccination-Program in Italy: A Health Strategy with a Relevant and Favorable Economic-Profile. International Journal of Environmental Research and Public Health 19:23, pages 16365.
Crossref
Crossref
Zhixi Liu, Mengying Li, David W. Hutton, Abram L. Wagner, Ye Yao, Wenlong Zhu, Lingsheng Cao, Shenglan Tang, Jinhua Pan, Yesheng Wang, Qi Zhao, Hong Ren, Ying Wang & Weibing Wang. (2022) Impact of the national hepatitis B immunization program in China: a modeling study. Infectious Diseases of Poverty 11:1.
Crossref
Crossref
Ali Mohammad Mokhtari, Mohsen Barouni, Mohsen Moghadami, Manica Negahdaripour & Alireza Mirahmadizadeh. (2022) Estimating costs of hepatitis B vaccination in infants: experimental evidence of the expanded program on immunization in Southern Iran. Journal of Public Health 44:3, pages 558-564.
Crossref
Crossref
Tom H Karlsen, Nick Sheron, Shira Zelber-Sagi, Patrizia Carrieri, Geoffrey Dusheiko, Elisabetta Bugianesi, Rachel Pryke, Sharon J Hutchinson, Bruno Sangro, Natasha K Martin, Michele Cecchini, Mae Ashworth Dirac, Annalisa Belloni, Miquel Serra-Burriel, Cyriel Y Ponsioen, Brittney Sheena, Alienor Lerouge, Marion Devaux, Nick Scott, Margaret Hellard, Henkjan J Verkade, Ekkehard Sturm, Giulio Marchesini, Hannele Yki-Järvinen, Chris D Byrne, Giovanni Targher, Aviad Tur-Sinai, Damon Barrett, Michael Ninburg, Tatjana Reic, Alison Taylor, Tim Rhodes, Carla Treloar, Claus Petersen, Christoph Schramm, Robert Flisiak, Marieta Y Simonova, Albert Pares, Philip Johnson, Alessandro Cucchetti, Isabel Graupera, Christos Lionis, Elisa Pose, Núria Fabrellas, Ann T Ma, Juan M Mendive, Vincenzo Mazzaferro, Harry Rutter, Helena Cortez-Pinto, Deirdre Kelly, Robyn Burton, Jeffrey V Lazarus, Pere Ginès, Maria Buti, Philip N Newsome, Patrizia Burra & Michael P Manns. (2022) The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. The Lancet 399:10319, pages 61-116.
Crossref
Crossref
Carmit Netanel, Omer Ben-Aharon, Ziv Ben-Ari, Gabriel Chodick, Emilia Anis & Racheli Magnezi. (2021) Evaluation of a universal hepatitis B vaccination program and antenatal screening for hepatitis B surface antigen: Results from a real-world study 2015–2016. Vaccine 39:48, pages 7101-7107.
Crossref
Crossref
Michele Pinon, Laura Giugliano, Emanuele Nicastro, Omar Kakaa, Alessandra Coscia, Caterina Carbonara, Lorenzo D’Antiga & Pier Luigi Calvo. (2021) Timely Birth Dose Vaccine to Prevent Vertical Transmission of Hepatitis B: A Single Center Experience on the Road to the WHO Elimination Goals in Italy. Vaccines 9:7, pages 801.
Crossref
Crossref
Panupong Upala, Tawatchai Apidechkul, Ratipark Tamornpark, Chalitar Chomchoei & Fartima Yeemard. (2020) Seroprevalence and factors associated with hepatitis B infection among the hill tribe adult population in Thailand: a cross-sectional study. BMC Infectious Diseases 20:1.
Crossref
Crossref
Mohsen Moghadami, Nazanin Dadashpour, Ali Mohammad Mokhtari, Mostafa Ebrahimi & Alireza Mirahmadizadeh. (2019) The effectiveness of the national hepatitis B vaccination program 25 years after its introduction in Iran: a historical cohort study. The Brazilian Journal of Infectious Diseases 23:6, pages 419-426.
Crossref
Crossref
Eva Borràs, Luis Urbiztondo, Glòria Carmona, Mireia Jané, Irene Barrabeig, M. Rosa Sala, J.P. Jorgina Balañà, Maria Company, Ignasi Parrón, Pere Godoy, Cristina Rius, Núria Soldevila, Carmen Cabezas & Àngela Domínguez. (2019) Effectiveness and impact of the hepatitis B vaccination program in preadolescents in Catalonia 21 years after its introduction. Vaccine 37:9, pages 1137-1141.
Crossref
Crossref
Francesco P. Bianchi, Maria S. Gallone, Maria F. Gallone, Angela M. V. Larocca, Luigi Vimercati, Michele Quarto & Silvio Tafuri. (2019) HBV seroprevalence after 25 years of universal mass vaccination and management of non-responders to the anti-Hepatitis B vaccine: An Italian study among medical students. Journal of Viral Hepatitis 26:1, pages 136-144.
Crossref
Crossref
Geoffrey Dusheiko & Kosh Agarwal. (2018) Delineating the global challenges of hepatitis B virus infection. The Lancet Gastroenterology & Hepatology 3:6, pages 372-373.
Crossref
Crossref
Assemien Boa, Alfred Douba, Hervé Menan, Alain Attia, Thimothée Ouassa, Joseph Bi Vroh Bénié, Armand Abokon, Mireille Dosso, Paul Aholi, Marguerite Timité-Konan, Raphaël Yao Abauleth, Emmanuel Bissagnéné, Joseph Aka, Jean Claude Yavo, Bonny Jean Sylvain, Germaine Siguifota Ouattara, Daniel Kouadio Ekra, Kadidia Sow, Jules N’guessan Kouassi, Éric Martial Kouakou Ahoussou & Raphaël Kalet Dally. (2017) Plaidoyer pour l’introduction du vaccin contre l’hépatite virale B à la naissance en Côte d’Ivoire. Santé Publique Vol. 29:5, pages 751-760.
Crossref
Crossref
Rebecca Masters, Elspeth Anwar, Brendan Collins, Richard Cookson & Simon Capewell. (2017) Return on investment of public health interventions: a systematic review. Journal of Epidemiology and Community Health 71:8, pages 827-834.
Crossref
Crossref
Yang Zhou, Hanqing He, Xuan Deng, Rui Yan, Xuewen Tang, Shuyun Xie & Jun Yao. (2017) Significant reduction in notification and seroprevalence rates of hepatitis B virus infection among the population of Zhejiang Province, China, aged between 1 and 29 years from 2006 to 2014. Vaccine 35:34, pages 4355-4361.
Crossref
Crossref
C. Ramière, L. Roche, C. Scholtès, J. Iwaz, J. Saison, R. Ecochard & P. André. (2016) Evolution of the incidence of hepatitis B virus infection and immunization rates in a large French cohort born between 1960 and 1994. Clinical Microbiology and Infection 22:10, pages 889.e1-889.e7.
Crossref
Crossref
Zhen-Zi Wang, Ming-Qiang Li, Ping Wang, Zhen-Xing Yang, Lin Wei, Ying Zeng, Yan-Ping Li, Ling Yan, Xue-En Liu & Hui Zhuang. (2016) Comparative immunogenicity of hepatitis B vaccine with different dosages and schedules in healthy young adults in China. Vaccine 34:8, pages 1034-1039.
Crossref
Crossref
R. Orlando, M. Foggia, A. E. Maraolo, S. Mascolo, G. Palmiero, O. Tambaro & G. Tosone. (2015) Prevention of hepatitis B virus infection: from the past to the future. European Journal of Clinical Microbiology & Infectious Diseases 34:6, pages 1059-1070.
Crossref
Crossref
Fabio Lugoboni, Raimondo Pavarin, Chiara Resentera & Daniele Gambini. (2015) Let It “B”? The Role of Hepatitis B Universal Vaccination among Italian Problematic Drug Users. International Journal of Environmental Research and Public Health 12:4, pages 3979-3992.
Crossref
Crossref
Ada Wai-chi Lin & Ka-hing Wong. (2013) Long-term protection of neonatal hepatitis B vaccination in a 30-year cohort in Hong Kong. Journal of Hepatology 59:6, pages 1363-1364.
Crossref
Crossref